V. Grisendi

发表

Reference values in ovarian response to controlled ovarian stimulation throughout the reproductive period

A. Volpe, C. Argento, M. Plebani, 2014, Gynecological Endocrinology.

Age-specific reference values for serum FSH and estradiol levels throughout the reproductive period

A. Volpe, C. Argento, M. Plebani, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history.

E. Papaleo, A. Volpe, C. Argento, 2012, European journal of obstetrics, gynecology, and reproductive biology.

The menstrual cycle regularization following d-chiro-inositol treatment in PCOS women: a retrospective study

A. La Marca, G. Sighinolfi, A. Cianci, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

External validation of anti-Müllerian hormone based prediction of live birth in assisted conception

A. McConnachie, S. Nelson, A. La Marca, 2013, Journal of Ovarian Research.

How Much Does AMH Really Vary in Normal Women?

A. La Marca, G. Griesinger, V. Grisendi, 2013, International journal of endocrinology.

AMH and Medically Assisted Reproduction

V. Grisendi, A. Marca, Valentina Grisendi, 2020 .

How to personalize ovarian stimulation in clinical practice

A. La Marca, G. Sighinolfi, V. Grisendi, 2017, Journal of the Turkish German Gynecological Association.

Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.

S. Zaffagnini, E. Papaleo, A. La Marca, 2016, European journal of obstetrics, gynecology, and reproductive biology.

Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study

S. Sunkara, C. Argento, A. La Marca, 2015, Journal of Assisted Reproduction and Genetics.

Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.

C. Argento, F. Fiorentino, A. La Marca, 2017, Fertility and sterility.

The ovarian follicular pool and reproductive outcome in women

E. Papaleo, A. Volpe, C. Argento, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.

M. Simoni, A. Volpe, C. Argento, 2013, Fertility and sterility.

Chronic endometritis in recurrent implantation failure: Use of prednisone and IVF outcome.

F. Facchinetti, A. La Marca, G. Sighinolfi, 2022, Journal of Reproductive Immunology.

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification

A. La Marca, E. Mastellari, V. Grisendi, 2019, Front. Endocrinol..

Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle‐stimulating hormone starting dose in in vitro fertilisation cycles

E. Papaleo, A. Volpe, C. Argento, 2012, BJOG : an international journal of obstetrics and gynaecology.

Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count

E. Papaleo, A. Volpe, C. Argento, 2013, Journal of Ovarian Research.

Possibilities and limits of ovarian reserve testing in ART.

M. Carbone, A. Volpe, C. Argento, 2012, Current pharmaceutical biotechnology.

Individualization of controlled ovarian stimulation in vitro fertilization using ovarian reserve markers.

A. La Marca, V. Grisendi, Valentina Grisendi, 2017, Minerva ginecologica.